购物车
0
有库存
HIT212672359
 sdf 文件
结构编辑
类似物检索
HIT212672359
  • HIT ID:HIT212672359
  • Cas No:2454244-02-9
  • 常用名:IRAK4-IN-6
  • IUPAC:methyl 4-[(1r,4r)-4-{[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino}cyclohexyl]piperazine-1-carboxylate
    IUPAC:methyl 4-[(1r,4r)-4-{[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino}cyclohexyl]piperazine-1-carboxylate
  • InChI key:RPGMSHCJIWHISY-IRJFHVNHSA-N
  • 分子式:C25H32N10O2
  • 分子量:504.599
  • 氢键供体数 (HBD):2
  • 氢键受体数 (HBA):9
  • LogP:2.103199
  • SMILES:COC(=O)N1CCN(CC1)[C@H]1CC[C@@H](CC1)Nc1nc(Nc2cnn(C)c2)nc2ccc(CC#N)nc12 |wU:13.17,wD:10.10,(10.67,-12.32,;9.34,-11.55,;9.34,-10.01,;10.67,-9.24,;8,-9.24,;6.67,-10.01,;5.33,-9.24,;5.33,-7.7,;6.67,-6.93,;8,-7.7,;4,-6.93,;4,-5.39,;2.67,-4.62,;1.33,-5.39,;1.33,-6.93,;2.67,-7.7,;,-4.62,;,-3.08,;-1.33,-2.31,;-1.33,-.77,;-2.67,,;-2.67,1.54,;-1.42,2.45,;-1.9,3.91,;-3.44,3.91,;-4.34,5.16,;-3.91,2.45,;;1.33,-.77,;2.67,,;4,-.77,;4,-2.31,;5.33,-3.08,;5.33,-4.62,;5.33,-6.16,;2.67,-3.08,;1.33,-2.31,)|
    SMILES:COC(=O)N1CCN(CC1)[C@H]1CC[C@@H](CC1)Nc1nc(Nc2cnn(C)c2)nc2ccc(CC#N)nc12 |wU:13.17,wD:10.10,(10.67,-12.32,;9.34,-11.55,;9.34,-10.01,;10.67,-9.24,;8,-9.24,;6.67,-10.01,;5.33,-9.24,;5.33,-7.7,;6.67,-6.93,;8,-7.7,;4,-6.93,;4,-5.39,;2.67,-4.62,;1.33,-5.39,;1.33,-6.93,;2.67,-7.7,;,-4.62,;,-3.08,;-1.33,-2.31,;-1.33,-.77,;-2.67,,;-2.67,1.54,;-1.42,2.45,;-1.9,3.91,;-3.44,3.91,;-4.34,5.16,;-3.91,2.45,;;1.33,-.77,;2.67,,;4,-.77,;4,-2.31,;5.33,-3.08,;5.33,-4.62,;5.33,-6.16,;2.67,-3.08,;1.33,-2.31,)|
  • IRAK4-IN-6 是一种选择性的、口服有效的IRAK 抑制剂,IC50为 4 nM,靶向 MyD88 L265P 突变型弥漫性大 B 细胞淋巴瘤。
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    8-10周
    纯度
    -
    ¥ 13,200.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~